III. Intracerebral hemorrhage

Journal of Stroke and Cerebrovascular Diseases

Volumn 20, Issue 4 SUPPL., 2011, Pages

  Shinohara, Yukito ^a,h   Yanagihara, Takehiko ^b   Abe, Koji ^c   Yoshimine, Toshiki ^b   Fujinaka, Toshiyuki ^d   Chuma, Takayo ^e   Ochi, Fumio ^f   Nagayama, Masao ^g   Ogawa, Akira ⁱ   Suzuki, Norihiro ^j   Katayama, Yasuo ^k   Kimura, Akio ^j   Yasui, Nobuyuki ^d  

^a Federation of National Public Service Personnel Mutual Aid Associations   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d Akita Prefectural Hospital Organization   (Japan)

^e Shiga Medical Center for Adult Diseases   (Japan)

^f Self Defense Forces Central Hospital   (Japan)

^g International University of Health and Welfare   (Japan)

^h Japan Stroke Society   (Japan)

ⁱ IWATE MEDICAL UNIVERSITY   (Japan)

^j KEIO UNIVERSITY   (Japan)

^k NIPPON MEDICAL SCHOOL   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CIMETIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FAMOTIDINE; GLYCEROL; HEPARIN; LANSOPRAZOLE; MANNITOL; NICARDIPINE; NIFEDIPINE; NILVADIPINE; NIMODIPINE; NITRATE; OMEPRAZOLE; PLACEBO; RANITIDINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; VERAPAMIL;

ACUTE HEART INFARCTION; ALCOHOL CONSUMPTION; ANTICOAGULANT THERAPY; ANTICONVULSANT THERAPY; ANTIHYPERTENSIVE THERAPY; ARTIFICIAL EMBOLISM; BASAL GANGLION HEMORRHAGE; BLOOD PRESSURE REGULATION; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN ARTERY ANEURYSM; BRAIN EDEMA; BRAIN HEMANGIOMA; BRAIN HEMORRHAGE; BRAIN SURGERY; BRAIN TUMOR; BRAINSTEM HEMORRHAGE; CAUDATE NUCLEUS HEMORRHAGE; CAVERNOUS HEMANGIOMA; CEREBELLUM HEMORRHAGE; CHRONIC KIDNEY FAILURE; COMPRESSION GARMENT; DEEP VEIN THROMBOSIS; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; DRUG CONTRAINDICATION; DRUG DOSE TITRATION; DURAL ARTERIOVENOUS FISTULA; EXERCISE; FRUIT; GLOMERULUS FILTRATION RATE; HEMATOMA; HEMIPLEGIA; HEMODIALYSIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INDUCED HYPOTHERMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; LIFESTYLE MODIFICATION; LIVER DISEASE; LOW DRUG DOSE; LUNG EMBOLISM; MAJOR DEPRESSION; MASSAGE; META ANALYSIS (TOPIC); MORBIDITY; MORTALITY; NEUROLOGICAL COMPLICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PEDIATRICS; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATION CONTROL; REVIEW; SECONDARY PREVENTION; SEIZURE; STEREOTACTIC RADIOSURGERY; STOMACH MUCOSA LESION; STOMACH ULCER; STRESS ULCER; STROKE; SUBCORTICAL HEMORRHAGE; SYSTOLIC BLOOD PRESSURE; THALAMUS HEMORRHAGE; VEGETABLE;

EID: 80051747817     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2011.05.005     Document Type: Article

References (366)

1. Health and Welfare Statistics Association. Trends in national health. J Health Welfare Stat 2001;48:406-413 (in Japanese)
2. Ueshima H. International comparison of stroke: Mortality from stroke, its prevalence and characteristics in Japan. Prev Gerontol 2002;1:10-15 (in Japanese)
3. Fujishima M. Cardiovascular disease in the elderly: The Hisayama Study. Nippon Ronen Igakkai Zasshi 1999;36:16-21 (in Japanese) (Pubitemid 29197708)
4. Sudlow CL, Warlow CP; International Stroke Incidence Collaboration. Comparable studies of the incidence of stroke and its pathological types: Results from an international collaboration. Stroke 1997;28:491-499 (Pubitemid 27118367)
5. Suzuki K. For prevention of stroke: Characteristics of stroke in Japan. Prev Gerontol 2002;1:16-22 (in Japanese)
6. Suzuki K. Cerebrovascular disorders and treatment of hypertension: Role of hypertension treatment in stroke prevention. J Blood Press 2002;9:871-877 (in Japanese)
7. Suzuki K, Sakamoto T. Clinical epidemiology of cerebral hemorrage. In Strokology in the era of intervention, ed by Shinohara Y, Nippon Rinsho. 2006, 64(suppl); 315-319 (in Japanese)
8. Japanese Society of Hypertension, Committee on Guidelines for the Management of Hypertension. Guidelines for the management of hypertension, 2004. Tokyo: Japanese Society of Hypertension 2004 p. 14
9. Kanaya H, Saiki I, Ohuchi T, et al. Hypertensive intracerebral hemorrhage in Japan: Update on surgical treatment. New York: Raven;1983. p. 147-163
10. Kanaya H. Treatment of hypertensive intracerebral hemorrhage: Results of a national survey. Jpn J Stroke 1990;12:509-524 (in Japanese)
11. Kanaya H, Kuroda K. Development in neurosurgical approaches to hypertensive intracerebral hemorrhage in Japan. In: Kaufman HH, editor. Intracerebral hematomas. New York: Raven;1992. p. 197-209
12. Kanaya H, Yukawa H, Ito Z, et al. Neurologic grading for patients with hypertensive intracerebral hemorrhage and a classification for hematoma location of computed tomography. In Proceedings of the 7th Conference on Surgical Treatment of Stroke. Neuron Publishing Co. Ltd., Tokyo, Japan 1978; p. 265-270 (in Japanese)
13. Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): A randomised trial. Lancet 2005;365:387-397 (Pubitemid 40179225)
14. Zia E, Hedblad B, Pessah-Rasmussen H, et al. Blood pressure in relation to the incidence of cerebral infarction and intracerebral hemorrhage. Hypertensive hemorrhage: Debated nomenclature is still relevant. Stroke 2007;38:2681-2685 (Pubitemid 47494004)
15. Kim HC, Nam CM, Jee SH, et al. Comparison of blood pressure-associated risk of intracerebral hemorrhage and subarachnoid hemorrhage: Korea Medical Insurance Corporation Study. Hypertension 2005;46:393-397 (Pubitemid 41099175)
16. Zhang H, Thijs L, Staessen JA. Blood pressure lowering for primary and secondary prevention of stroke. Hypertension 2006;48:187-195 (Pubitemid 44321393)
17. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-1041
18. Metoki H, Ohkubo T, Kikuya M, et al. Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: The Ohasama Study. Hypertension 2006;47:149-154 (Pubitemid 43189756)
19. Dauchet L, Amouyel P, Dallongeville J. Fruit and vegetable consumption and risk of stroke: A meta-analysis of cohort studies. Neurology 2005;65:1193-1197 (Pubitemid 41508210)
20. Sauvaget C, Nagano J, Allen N, et al. Vegetable and fruit intake and stroke mortality in the Hiroshima/Nagasaki Life Span Study. Stroke 2003;34:2355-2360 (Pubitemid 37221941)
21. Reynolds K, Lewis LB, Nolen JDL, et al. Alcohol consumption and risk of stroke: A meta-analysis. JAMA 2003;289:579-588 (Pubitemid 37428630)
22. Kiyohara Y, Kato I, Iwamoto H, et al. The impact of alcohol and hypertension on stroke incidence in a general Japanese population: The Hisayama Study. Stroke 1995;26:368-372
23. Ebrahim S, Sung J, Song YM, et al. Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean National Health System prospective cohort study. BMJ 2006;333:22-25 (Pubitemid 44406841)
24. Amarenco P, Labreuche J, Lavallee P, et al. Statins in stroke prevention and carotid atherosclerosis: Systematic review and up-to-date meta-analysis. Stroke 2004;35:2902-2909 (Pubitemid 39565192)
25. Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. New Engl J Med 2006;355:549-559
26. Amarenco P, Goldstein LB, Szarek M, et al. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 2007;38:3198-3204 (Pubitemid 350175737)
27. Vergouwen MD, de Haan RJ, Vermeulen M, et al. Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke 2008;39:497-502 (Pubitemid 351619482)
28. Goldstein LB, Amarenco P, Szarek M, et al, on behalf of the SPARCL Investigators. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology 2008;70:2364-2370
29. Hart RG, Tonarelli SB, Pearce LA. Avoiding central nervous system bleeding during antithrombotic therapy: Recent data and ideas. Stroke 2005;36:1588-1593 (Pubitemid 40967537)
30. Lip GY, Frison L, Grind M, on behalf of the SPORTIF Investigators. Effect of hypertension on anticoagulated patients with atrial fibrillation. Eur Heart J 2007;28:752-759 (Pubitemid 46439230)
31. Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in highrisk patients (MATCH): Randomised, double-blind, placebo-controlled trial. Lancet 2004;364:331-337
32. Iseki K, Fukiyama K; Okinawa Dialysis Study (OKIDS) Group. Clinical demographics and long-term prognosis after stroke in patients on chronic haemodialysis. Nephrol Dial Transplant 2000;15:1808-1813
33. Bos MJ, Koudstaal PJ, Hofman A, et al. Decreased glomerular filtration rate is a risk factor for hemorrhagic but not for ischemic stroke: The Rotterdam Study. Stroke 2007;38:3127-3132 (Pubitemid 350175725)
34. Perkovic V, Ninomiya T, Arima H, et al. Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: Data from the PROGRESS Study. J Am Soc Nephrol 2007;18:2766-2772 (Pubitemid 47531204)
35. Janghorbani M, Hu FB, Willett WC, et al. Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: The Nurses' Health Study. Diabetes Care 2007;30:1730-1735 (Pubitemid 47036344)
36. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-713
37. Wilcox R, Bousser MG, Betteridge DJ, et al. Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke: Results from PROactive (Prospective Pioglitzone Clinical Trial in Macrovascular Events 04). Stroke 2007;38:865-873 (Pubitemid 46568445)
38. Naka H, Nomura E, Takahashi T, et al. Combinations of the presence or absence of cerebral microbleeds and advanced white matter hyperintensity as predictors of subsequent stroke types. AJNR Am J Neuroradiol 2006;27: 830-835 (Pubitemid 44897731)
39. Naka H, Nomura E, Wakabayashi S, et al. Frequency of asymptomatic microbleeds on T2*-weighted MR images of patients with recurrent stroke: Association with combination of stroke subtypes and leukoaraiosis. AJNR Am J Neuroradiol 2004;25:714-719 (Pubitemid 38657651)
40. Toyoda T, Yasaka M, Iwade K, et al; for the Bleeding with Antithrombotic Therapy (BAT) Study Group. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: A prospective, multicenter, observational study. Stroke 2008;39:1740-1745
41. Toyoda K, Yasaka M, Uchiyama S, et al; on behalf of the Bleeding With Antithrombotic Therapy (BAT) Study Group. Blood pressure levels and bleeding events during antithrombotic therapy: The Bleeding with Antithrombotic Therapy (BAT) study. Stroke 2010;41:1440-1444
42. Mayer SA, Brun NC, Broderick J, et al. Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial. Neurocrit Care 2006;4:206-214 (Pubitemid 43998013)
43. Mayer SA, Brun NC, Broderick J, et al. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. Stroke 2005;36:74-79 (Pubitemid 40054178)
44. Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005;352:777-785
45. Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008;358:2127-2137 (Pubitemid 351679599)
46. Steiner T, Kaste M, Forsting M, et al; European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Recommendations for the management of intracranial haemorrhage, part I: Spontaneous intracerebral haemorrhage. Cerebrovasc Dis 2006;22:294-316 (Pubitemid 44338094)
47. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults, 2007 update: A guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007;38:2001-2023 (Pubitemid 46850654)
48. Piriyawat P, Morgenstern LB, Yawn DH, et al. Treatment of acute intracerebral hemorrhage with epsilon-aminocaproic acid: A pilot study. Neurocrit Care 2004;1:47-51
49. Sorimachi T, Fujii Y, Morita K, et al. Predictors of hematoma enlargement in patients with intracerebral hemorrhage treated with rapid administration of antifibrinolytic agents and strict blood pressure control. J Neurosurg 2007;106:250-254 (Pubitemid 46203151)
50. You H, Al-Shahi R. Haemostatic drug therapies for acute primary intracerebral haemorrhage. Cochrane Database Syst Rev 2006:CD005951
51. Dandapani BK, Suzuki S, Kelley RE, et al. Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke 1995;26:21-24
52. Meyer JS, Bauer RB. Medical treatment of spontaneous intracranial hemorrhage by the use of hypotensive drugs. Neurology 1962;12:36-47
53. Maruishi M, Shima T, Okada Y, et al. Involvement of fluctuating high blood pressure in the enlargement of spontaneous intracerebral hematoma. Neurol Med Chir (Tokyo) 2001;41:300-305
54. Kazui S. Enlargement of intracerebral hemorrhage: Its incidence, temporal course and associated factors. Recent Adv Cardiovasc Dis 1997;XVIII:77-84 (in Japanese)
55. Isozumi K, Hori S, Tanahashi N, et al. Superacute phase blood pressure elevation may relate to massive hematoma in hypertensive putaminal hemorrhage. Keio J Med 1997;46:81-84 (Pubitemid 127471206)
56. Hondo H. Perioperative blood pressure management of patients with hypertensive intracerebral hemorrhage in the acute stage. Jpn J Stroke 1997;19:432-436 (in Japanese)
57. Jauch EC, Lindsell CJ, Adeoye O, et al. Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. Stroke 2006;37:2061-2065 (Pubitemid 44309904)
58. Broderick JP, Diringer MN, Hill MD, et al. Determinants of intracerebral hemorrhage growth: An exploratory analysis. Stroke 2007;38:1072-1075 (Pubitemid 46568477)
59. Qureshi AI, Qureshi Z, Palesch YY; ATACH Investigators. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) Trial: Final results. Presented at the American Stroke Assication 2009 International Stroke Conference, San Diego, CA, February 17-20, 2009
60. Anderson CS, Huang Y, Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): A randomised pilot trial. Lancet Neurol 2008;7:391-399
61. Blood Pressure in Acute Stroke Collaboration (BASC). Vasoactive drugs for acute stroke. Cochrane Database Syst Rev 2000:CD002839
62. Barer DH, Cruickshank JM, Ebrahim SB, et al. Low-dose beta-blockade in acute stroke (BEST trial): An evaluation. BMJ (Clin Res Ed) 1988;296:737-741 (Pubitemid 18066502)
63. Hojo A, Nakagawara J, Takeda R, et al. Antihypertensive effect and impact on cerebral circulatory dynamics of nitroglycerin in patients with acute-phase hypertensive intracerebral hemorrhage. Jpn J Intens Care Med 1993;17:1101-1109 (in Japanese)
64. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults, 2007 update: A guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007;38:2001-2023 (Pubitemid 46850654)
65. Kuroda K, Kuwata N, Sato N, et al. Changes in cerebral blood flow accompanied with reduction of blood pressure treatment in patients with hypertensive intracerebral hemorrhages. Neurol Res 1997;19:169-173 (Pubitemid 27190708)
66. Wagenknecht LE, Furberg CD, Hammon JW, et al. Surgical bleeding: Unexpected effect of a calcium antagonist. BMJ 1995;310:776-777
67. Gore JM, Sloan M, Price TR, et al. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial. Circulation 1991;83:448-459
68. Steiner T, Kaste M, Forsting M, et al; European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Recommendations for the management of intracranial haemorrhage, part I: Spontaneous intracerebral haemorrhage. Cerebrovasc Dis 2006;22:294-316 (Pubitemid 44338094)
69. Nishikawa T, Omote K, Namiki A, et al. The effects of nicardipine on cerebrospinal fluid pressure in humans. Anesth Analg 1986;65:507-510 (Pubitemid 16143303)
70. Takenaka T, Handa J. Cerebrovascular effects of YC-93, a new vasodilator, in dogs, monkeys and human patients. Int J Clin Pharmacol Biopharm 1979;17:1-11 (Pubitemid 9109748)
71. Nishiyama T, Yokoyama T, Matsukawa T, et al. Continuous nicardipine infusion to control blood pressure after evacuation of acute cerebral hemorrhage. Can J Anaesth 2000;47:1196-1201 (Pubitemid 32098995)
72. Ronning OM, Guldvog B. Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial. Stroke 1999;30:2033-2037 (Pubitemid 29473245)
73. Lim J, Lim WK, Yeo TT, et al. Management of haemorrhagic stroke with hyperbaric oxygen therapy: A case report. Singapore Med J 2001;42:220-223
74. Kanno T, Nonomura K. Hyperbaric oxygen therapy to determine the surgical indication of moderate hypertensive intracerebral hemorrhage. Minim Invasive Neurosurg 1996;39:56-59 (Pubitemid 26199685)
75. Stocchetti N, Maas AI, Chieregato A, et al. Hyperventilation in head injury: A review. Chest 2005;127:1812-1827 (Pubitemid 46218813)
76. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults, 2007 update: A guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007;38:2001-2023 (Pubitemid 46850654)
77. Fukuuchi Y, Hirai H, Ito Y, et al. Treatment of neurological disorders with intravenous hypertonic glycerol, I: Clinical effects of saline containing 10% (W/V) glycerol (CG-A2P). Jpn J Clin Exp Med 1978;55:929-937 (in Japanese)
78. Gotoh F, Tazaki Y, Fukuuchi Y, et al. Treatment of neurological disorders with intravenous hypertonic glycerol, II: Clinical effects of saline containing 10% (W/V) glycerol and 5% (W/V) fructose (CG-A30). Jpn J Clin Exp Med 1978;55:2327-2335 (in Japanese)
79. Yu YL, Kumana CR, Lauder IJ, et al. Treatment of acute cerebral hemorrhage with intravenous glycerol: A doubleblind, placebo-controlled, randomized trial. Stroke 1992;23:967-971
80. Misra UK, Kalita J, Ranjan P, et al. Mannitol in intracerebral hemorrhage: A randomized controlled study. J Neurol Sci 2005;234:41-45 (Pubitemid 40910342)
81. Bereczki D, Liu M, Prado GF, et al. Cochrane report: A systematic review of mannitol therapy for acute ischemic stroke and cerebral parenchymal hemorrhage. Stroke 2000;31:2719-2722
82. Tellez H, Bauer RB. Dexamethasone as treatment in cerebrovascular disease, 1: A controlled study in intracerebral hemorrhage. Stroke 1973;4:541-546
83. Poungvarin N, Bhoopat W, Viriyavejakul A, et al. Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med 1987;316:1229-1233 (Pubitemid 17069351)
84. Desai P, Prasad K. Dexamethasone is not necessarily unsafe in primary supratentorial intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 1998;65:799-800 (Pubitemid 28486672)
85. Ogun SA, Odusote KA. Effectiveness of high-dose dexamethasone in the treatment of acute stroke. West Afr J Med 2001;20:1-6
86. Feigin VL, Anderson N, Rinkel GJ, et al. Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage. Cochrane Database Syst Rev 2005:CD004583
87. Ng I, Lim J, Wong HB. Effects of head posture on cerebral hemodynamics: Its influences on intracranial pressure, cerebral perfusion pressure, and cerebral oxygenation. Neurosurgery 2004;54:593-598 (Pubitemid 38298730)
88. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults, 2007 update: A guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007;38:2001-2023
89. Passero S, Rocchi R, Rossi S, et al. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia 2002;43:1175-1180 (Pubitemid 35176125)
90. Berges S, Moulin T, Berger E, et al. Seizures and epilepsy following strokes: Recurrence factors. Eur Neurol 2000;43:3-8 (Pubitemid 30045315)
91. Bladin CF, Alexandrov AV, Bellavance A, et al. Seizures after stroke: A prospective multicenter study. Arch Neurol 2000;57:1617-1622
92. Kilpatrick CJ, Davis SM, Tress BM, et al. Epileptic seizures in acute stroke. Arch Neurol 1990;47:157-160 (Pubitemid 20058111)
93. Davenport RJ, Dennis MS, Warlow CP. Gastrointestinal hemorrhage after acute stroke. Stroke 1996;27:421-424 (Pubitemid 26081435)
94. Schwarz S, Hafner K, Aschoff A, et al. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology 2000;54:354-361 (Pubitemid 30078066)
95. Rossi S, Zanier ER, Mauri I, et al. Brain temperature, body core temperature, and intracranial pressure in acute cerebral damage. J Neurol Neurosurg Psychiatry 2001;71:448-454 (Pubitemid 32906866)
96. Kammersgaard LP, Rasmussen BH, Jorgensen HS, et al. Feasibility and safety of inducing modest hypothermia in awake patients with acute stroke through surface cooling: A case-control study. The Copenhagen Stroke Study. Stroke 2000;31:2251-2256
97. Gregory PC, Kuhlemeier KV. Prevalence of venous thromboembolism in acute hemorrhagic and thromboembolic stroke. Am J Phys Med Rehabil 2003;82:364-369 (Pubitemid 36504590)
98. Fraser DG, Moody AR, Morgan PS, et al. Diagnosis of lower-limb deep venous thrombosis: A prospective blinded study of magnetic resonance direct thrombus imaging. Ann Intern Med 2002;136:89-98 (Pubitemid 34073933)
99. Lacut K, Bressollette L, Le Gal G, et al. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology 2005;65:865-869 (Pubitemid 41362131)
100. Boeer A, Voth E, Henze T, et al. Early heparin therapy in patients with spontaneous intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 1991;54:466-467
101. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults, 2007 update: A guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007;38:2001-2023
102. Irie K, Yamaguchi T, Minematsu K, et al. The J-curve phenomenon in stroke recurrence. Stroke 1993;24:1844-1849 (Pubitemid 23352714)
103. Passero S, Burgalassi L, D'Andrea P, et al. Recurrence of bleeding in patients with primary intracerebral hemorrhage. Stroke 1995;26:1189-1192
104. Arakawa S, Saku Y, Ibayashi S, et al. Blood pressure control and recurrence of hypertensive brain hemorrhage. Stroke 1998;29:1806-1809 (Pubitemid 28399968)
105. Bae H, Jeong D, Doh J, et al. Recurrence of bleeding in patients with hypertensive intracerebral hemorrhage. Cerebrovasc Dis 1999;9:102-108 (Pubitemid 29084225)
106. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-1041
107. Chapman N, Huxley R, Anderson C, et al. Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: The PROGRESS Trial. Stroke 2004;35:116-121 (Pubitemid 38057603)
108. O'Donnell HC, Rosand J, Knudsen KA, et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 2000;342:240-245 (Pubitemid 30058955)
109. Hill MD, Silver FL, Austin PC, et al. Rate of stroke recurrence in patients with primary intracerebral hemorrhage. Stroke 2000;31:123-127 (Pubitemid 30035763)
110. Neau JP, Ingrand P, Couderq C, et al. Recurrent intracerebral hemorrhage. Neurology 1997;49:106-113 (Pubitemid 27328689)
111. Kilpatrick CJ, Davis SM, Tress BM, et al. Epileptic seizures in acute stroke. Arch Neurol 1990;47:157-160 (Pubitemid 20058111)
112. GiroudM,Gras P, FayolleH, et al. Early seizures after acute stroke: A study of 1640 cases. Epilepsia 1994;35:959-964 (Pubitemid 24346301)
113. Burn J, Dennis M, Bamford J, et al. Epileptic seizures after a first stroke: The Oxfordshire Community Stroke Project. BMJ 1997;315:1582-1587 (Pubitemid 27522399)
114. Vespa PM, O'Phelan K, Shah M, et al. Acute seizures after intracerebral hemorrhage: A factor in progressive midline shift and outcome. Neurology 2003;60:1441-1446 (Pubitemid 36554803)
115. Kilpatrick CJ, Davis SM, Hopper JL, et al. Early seizures after acute stroke: Risk of late seizures. Arch Neurol 1992;49:509-511
116. Bladin CF, Alexandrov AV, Bellavance A, et al. Seizures after stroke: A prospective multicenter study. Arch Neurol 2000;57:1617-1622
117. Starkstein SE, Fedoroff JP, Price TR, et al. Apathy following cerebrovascular lesions. Stroke 1993;24:1625-1630 (Pubitemid 23315865)
118. Schwartz JA, Speed NM, Brunberg JA, et al. Depression in stroke rehabilitation. Biol Psychiatry 1993;33:694-699 (Pubitemid 23205325)
119. Fuh JL, Liu HC, Wang SJ, et al. Poststroke depression among the Chinese elderly in a rural community. Stroke 1997;28:1126-1129
120. Neau JP, Ingrand P, Mouille-Brachet C, et al. Functional recovery and social outcome after cerebral infarction in young adults. Cerebrovasc Dis 1998;8:296-302 (Pubitemid 28420797)
121. Pohjasvaara T, Leppavuori A, Siira I, et al. Frequency and clinical determinants of poststroke depression. Stroke 1998;29:2311-2317 (Pubitemid 28511949)
122. Kauhanen M, Korpelainen JT, Hiltunen P, et al. Poststroke depression correlates with cognitive impairment and neurological deficits. Stroke 1999;30:1875-1880 (Pubitemid 29411830)
123. Kim JS, Choi-Kwon S. Poststroke depression and emotional incontinence: Correlation with lesion location. Neurology 2000;54:1805-1810 (Pubitemid 30428409)
124. Robinson RG, Lipsey JR, Bolla-Wilson K, et al. Mood disorders in left-handed stroke patients. Am J Psychiatry 1985;142:1424-1429 (Pubitemid 16169876)
125. Shimoda K, Robinson RG. The relationship between poststroke depression and lesion location in long-term follow-up. Biol Psychiatry 1999;45:187-192 (Pubitemid 29079449)
126. Singh A, Herrmann N, Black SE. The importance of lesion location in poststroke depression: A critical review. Can J Psychiatry 1998;43:921-927 (Pubitemid 29173301)
127. Masada T, Makabe T, Kunishio K, et al. Depression following lntracerebral hemorrhage and the evaluation of cerebral blood flow by single-photon emission tomography. Brain Nerve 2007;59:165-168 (in Japanese)
128. Starkstein SE, Robinson RG, Price TR. Comparison of patients with and without poststroke major depression matched for size and location of lesion. Arch Gen Psychiatry 1988;45:247-252 (Pubitemid 18081673)
129. Morris PL, Robinson RG, Andrzejewski P, et al. Association of depression with 10-year poststroke mortality. Am J Psychiatry 1993;150:124-129 (Pubitemid 23059176)
130. Ramasubbu R, Robinson RG, Flint AJ, et al. Functional impairment associated with acute poststroke depression: The Stroke Data Bank Study. J Neuropsychiatry Clin Neurosci 1998;10:26-33 (Pubitemid 28135120)
131. Kimura M, Robinson RG, Kosier JT. Treatment of cognitive impairment after poststroke depression: A doubleblind treatment trial. Stroke 2000;31:1482-1486 (Pubitemid 30437491)
132. Andersen G, Vestergaard K, Lauritzen L. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994;25:1099-1104 (Pubitemid 24164745)
133. Dam M, Tonin P, De Boni A, et al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 1996;27:1211-1214 (Pubitemid 26226957)
134. Robinson RG, Schultz SK, Castillo C, et al. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: A placebo-controlled, double-blind study. Am J Psychiatry 2000;157:351-359 (Pubitemid 30145919)
135. Wiart L, Petit H, Joseph PA, et al. Fluoxetine in early poststroke depression: A double-blind placebocontrolled study. Stroke 2000;31:1829-1832 (Pubitemid 30620458)
136. Palomaki H, Kaste M, Berg A, et al. Prevention of poststroke depression: 1-year randomised placebo-controlled double-blind trial of mianserin with 6 month follow-up after therapy. J Neurol Neurosurg Psychiatry 1999;66:490-494 (Pubitemid 29145685)
137. Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): A randomised trial. Lancet 2005;365:387-397 (Pubitemid 40179225)
138. Mendelow AD, Unterberg A. Surgical treatment of intracerebral haemorrhage. Curr Opin Crit Care 2007;13:169-174 (Pubitemid 46328331)
139. Teernstra OP, Evers SM, Lodder J, et al. Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: A multicenter randomized controlled trial (SICHPA). Stroke 2003;34:968-974 (Pubitemid 36402971)
140. Pantazis G, Tsitsopoulos P, Mihas C, et al. Early surgical treatment vs conservative management for spontaneous supratentorial intracerebral hematomas: A prospective randomized study. Surg Neurol 2006;66:492-502
141. McKissock W, Richardson A, Taylor J. Primary intracerebral haemorrhage: A controlled trial of surgical and conservative treatment in 180 unselected cases. Lancet 1961;2:221-226
142. Juvela S, Heiskanen O, Poranen A, et al. The treatment of spontaneous intracerebral hemorrhage: A prospective randomized trial of surgical and conservative treatment. J Neurosurg 1989;70:755-758 (Pubitemid 19124189)
143. Batjer HH, Reisch JS, Allen BC, et al. Failure of surgery to improve outcome in hypertensive putaminal hemorrhage: A prospective randomized trial. Arch Neurol 1990;47:1103-1106 (Pubitemid 20326667)
144. Auer LM, Deinsberger W, Niederkorn K, et al. Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: A randomized study. J Neurosurg 1989;70:530-535 (Pubitemid 19100711)
145. Morgenstern LB, Frankowski RF, Shedden P, et al. Surgical treatment for intracerebral hemorrhage (STICH): A single-center,randomized clinical trial. Neurology 1998;51:1359-1363 (Pubitemid 28520558)
146. Zuccarello M, Brott T, Derex L, et al. Early surgical treatment for supratentorial intracerebral hemorrhage: A randomized feasibility study. Stroke 1999;30:1833-1839 (Pubitemid 29411823)
147. Hattori N, Katayama Y, Maya Y, et al. Impact of stereotactic hematoma evacuation on activities of daily living during the chronic period following spontaneous putaminal hemorrhage: A randomized study. J Neurosurg 2004;101:417-420 (Pubitemid 39100717)
148. Tan SH, Ng PY, Yeo TT, et al. Hypertensive basal ganglia hemorrhage:Aprospective study comparing surgical and nonsurgical management. Surg Neurol 2001;56:287-292 (Pubitemid 34003003)
149. Broderick J, Brott T, Tomsick T, et al. Management of intracerebral hemorrhage in a large metropolitan population. Neurosurgery 1994;34:882-887 (Pubitemid 24130069)
150. Volpin L, Cervellini P, Colombo F, et al. Spontaneous intracerebral hematomas:Anew proposal about the usefulness and limits of surgical treatment. Neurosurgery 1984;15:663-666 (Pubitemid 15179639)
151. van Loon J, Van Calenbergh F, Goffin J, et al. Controversies in the management of spontaneous cerebellar haemorrhage: A consecutive series of 49 cases and review of the literature. Acta Neurochir (Wien) 1993;122:187-193 (Pubitemid 23219662)
152. Da Pian R, Bazzan A, Pasqualin A. Surgical versus medical treatment of spontaneous posterior fossa haematomas: A cooperative study on 205 cases. Neurol Res 1984;6:145-151 (Pubitemid 15223068)
153. Kaneko M, Tanaka K, Shimada T, et al. Long-term evaluation of ultra-early operation for hypertensive intracerebral hemorrhage in 100 cases. J Neurosurg 1983;58: 838-842 (Pubitemid 13096636)
154. Firsching R, Huber M, Frowein RA. Cerebellar haemorrhage: Management and prognosis. Neurosurg Rev 1991;14:191-194
155. Kalff R, Feldges A, Mehdorn HM, et al. Spontaneous intracerebral hemorrhage. Neurosurg Rev 1992;15:177-186
156. Zumkeller M, Hollerhage HG, Proschl M, et al. The results of surgery for intracerebral hematomas. Neurosurg Rev 1992;15:33-36
157. Kaneko M, Koba T, Yokoyama T. Early surgical treatment for hypertensive intracerebral hemorrhage. J Neurosurg 1977;46:579-583 (Pubitemid 8084936)
158. Waga S, Yamamoto Y. Hypertensive putaminal hemorrhage: Treatment and results. Is surgical treatment superior to conservative one? Stroke 1983;14:480-485 (Pubitemid 13036768)
159. Koziarski A, Frankiewicz E. Medical and surgical treatment of intracerebellar haematomas. Acta Neurochir (Wien) 1991;110:24-28
160. Fujitsu K, Muramoto M, Ikeda Y, et al. Indications for surgical treatment of putaminal hemorrhage: Comparative study based on serial CT and time-course analysis. J Neurosurg 1990;73:518-525 (Pubitemid 20319468)
161. Kanno T, Sano H, Shinomiya Y, et al. Role of surgery in hypertensive intracerebral hematoma: A comparative study of 305 nonsurgical and 154 surgical cases. J Neurosurg 1984;61:1091-1099 (Pubitemid 15182255)
162. Coraddu M, Nurchi GC, Floris F, et al. Considerations about the surgical indication of the spontaneous cerebral haematomas. J Neurosurg Sci 1990;34:35-39 (Pubitemid 20274251)
163. Brambilla GL, Rodriguez y Baena R, Sangiovanni G, et al. Spontaneous intracerebral hemorrhage: Medical or surgical treatment. J Neurosurg Sci 1983;27:95-101 (Pubitemid 13020280)
164. Nieuwkamp DJ, de Gans K, Rinkel GJ, et al. Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: A systematic review of the literature. J Neurol 2000;247:117-121 (Pubitemid 30162526)
165. Bolander HG, Kourtopoulos H, Liliequist B, et al. Treatment of spontaneous intracerebral haemorrhage: A retrospective analysis of 74 consecutive cases with special reference to computed tomographic data. Acta Neurochir (Wien) 1983;67:19-28 (Pubitemid 13162657)
166. Mathew P, Teasdale G, Bannan A, et al. Neurosurgical management of cerebellar haematoma and infarct. J Neurol Neurosurg Psychiatry 1995;59:287-292
167. Niizuma H, Shimizu Y, Yonemitsu T, et al. Results of stereotactic aspiration in 175 cases of putaminal hemorrhage. Neurosurgery 1989;24:814-819 (Pubitemid 19157085)
168. Yokote H, Komai N, Nakai E, et al. Stereotactic evacuation of hypertensive cerebellar hemorrhage using plasminogen activator. No Shinkei Geka 1989;17:421-426 (in Japanese) (Pubitemid 19156533)
169. Kanaya H. Current situations of treatments of hypertensive intracerebral hemorrhage: Results of a national survey. Jpn J Stroke 1990;12:509-524 (in Japanese)
170. Gotoh F; Keio Cooperative Stroke Study Group. Comparison of conservative treatment and surgical treatment for hypertensive putaminal hemorrhage in 819 cases. Jpn J Stroke 1990;12:493-500
171. Gotoh F, Fukuuchi Y; Keio Cooperative Stroke Study Group. Comparison of conservative treatment and surgical treatment for thalamic hemorrhage in 556 cases. Jpn J Stroke 1992;14:72-78 (in Japanese)
172. Gotoh F, Fukuuchi Y; Keio Cooperative Stroke Study Group. Comparison of conservative treatment and surgical treatment for cerebellar hemorrhage in 118 cases. Jpn J Stroke 1992;14:487-494 (in Japanese)
173. Gotoh F, Fukuuchi Y; Keio Cooperative Stroke Study Group. Prognosis of pontine hemorrhage. Jpn J Stroke 1993;15:310-316
174. Fukushima T, Karasawa K, Sugiyama N, et al. CTstereotactic hematoma evacuation for hypertensive putaminal hemorrhage. Bull Nagoya City Univ Hosp 1999;21: 133-136 (in Japanese)
175. Yuki K, Kiya K, Kawamoto H, et al. Significance of stereotactic hematoma evacuation for thalamic hemorrhage.Med J Hiroshima Prefect Hosp 1997;29:117-123 (in Japanese)
176. Yanaka K, Meguro K, Fujita K, et al. Immediate surgery reduces mortality in deeply comatose patients with spontaneous cerebellar hemorrhage. Neurol Med Chir (Tokyo) 2000;40:295-300 (Pubitemid 30430172)
177. Kumasaka A, Shimoda M, Oda S, et al. Indications for surgical treatment of hypertensive cerebellar hemorrhage: Multivariate analysis of functional outcome. Jpn J Neurosurg 1999;8:33-40 (in Japanese) (Pubitemid 29058598)
178. Murata T, Shimotake K, Miyagawa H, et al. Stereotactic aspiration surgery and the treatment of hypertensive intracerebellar hemorrhage. J Jpn Assoc Acute Med 1999;10:356-361 (in Japanese)
179. Rabinstein AA, Atkinson JL, Wijdicks EF. Emergency craniotomy in patients worsening due to expanded cerebral hematoma: To what purpose? Neurology 2002;58:1367-1372 (Pubitemid 34507163)
180. Marquardt G, Wolff R, Sager A, et al. Subacute stereotactic aspiration of haematomas within the basal ganglia reduces occurrence of complications in the course of haemorrhagic stroke in non-comatose patients. Cerebrovasc Dis 2003;15:252-257 (Pubitemid 36438728)
181. Marquardt G,Wolff R, JanzenRW, et al. Basal ganglia haematomas in non-comatose patients: Subacute stereotactic aspiration improves long-term outcome in comparison to purely medical treatment. Neurosurg Rev 2005;28:64-69 (Pubitemid 40100865)
182. Morioka J, Fujii M, Kato S, et al. Surgery for spontaneous intracerebral hemorrhage has greater remedial value than conservative therapy. Surg Neurol 2006;65:67-73
183. Teernstra OP, Evers SM, Kessels AH. Meta-analyses in treatment of spontaneous supratentorial intracerebral haematoma. Acta Neurochir (Wien) 2006;148:521-528
184. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults, 2007 update: A guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007;38:2001-2023
185. Kirollos RW, Tyagi AK, Ross SA, et al. Management of spontaneous cerebellar hematomas: A prospective treatment protocol. Neurosurgery 2001;49:1378-1387 (Pubitemid 34215171)
186. Asakura K, Mizuno M, Yasui N. Clinical analysis of 24 cases of caudate hemorrhage . Neurol Med-Chir 1989;29:1107-1112 (Pubitemid 20268174)
187. Liliang PC, Liang CL, Lu CH, et al. Hypertensive caudate hemorrhage: Prognostic predictor, outcome, and role of external ventricular drainage. Stroke 2001;32:1195-1200
188. Yamaguchi Y, Nakagawa K, Watanabe H, et al. Primary intraventricular hemorrhage. Jpn J Neurosurg 2000;9:672-678
189. Roos YB, Hasan D, Vermeulen M. Outcome in patients with large intraventricular haemorrhages: A volumetric study. J Neurol Neurosurg Psychiatry 1995;58:622-624
190. Naff NJ. Intraventricular hemorrhage in adults. Curr Treat Options Neurol 1999;1:173-178
191. Akdemir H, Selcuklu A, Pasaoglu A, et al. Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. Neurosurg Rev 1995;18:95-100
192. Tung MY, Ong PL, SeowWT, et al.Astudy on the efficacy of intraventricular urokinase in the treatment of intraventricular haemorrhage. Br J Neurosurg 1998;12:234-239 (Pubitemid 28287240)
193. Naff NJ, Carhuapoma JR, Williams MA, et al. Treatment of intraventricular hemorrhage with urokinase: Effects on 30-day survival. Stroke 2000;31:841-847 (Pubitemid 30198425)
194. Andrews CO, Engelhard HH. Fibrinolytic therapy in intraventricular hemorrhage. Ann Pharmacother 2001;35:1435-1448 (Pubitemid 33042080)
195. Lapointe M, Haines S. Fibrinolytic therapy for intraventricular hemorrhage in adults. Cochrane Database Syst Rev 2002:CD003692
196. Naff NJ, Hanley DF, Keyl PM, et al. Intraventricular thrombolysis speeds blood clot resolution: Results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurgery 2004;54:577-83
197. Nakai E. Study of stereotactic hematoma dissolution and evacuation in hypertensive intracerebral hemorrhage. J Wakayama Med So 1999;50:33-42 (in Japanese)
198. Higashi S, Ueno M, Okada Y, et al. A new endoscopic neurosurgery for intracerebral hemorrhage: Induction of Echo-guidance peel-off sheath and steerable fiberscope. Surg Cerebral Stroke 2000;28:458-464 (in Japanese)
199. Kuroda K, Ogawa A. Comparative studies of surgical treatments for intracerebral hemorrhage: Echo-guide aspiration and CT-guided aspiration with neuroendoscopy. Jpn Neurosurg 1999;8:100-105 (Pubitemid 29091199)
200. Hayashi N, Nishimura S, Numagami Y, et al. Retrospective analysis of effects and complications in cases treated with endoscopic evacuation of intracerebral hemorrhage. Neuro Surg 2006;34:1233-1238 (Japanese) (Pubitemid 46063936)
201. Nishihara T, Morita A, Teraoka A, et al. Endoscopyguided removal of spontaneous intracerebral hemorrhage: Comparison with computed tomography-guided stereotactic evacuation. Childs Nerv Syst 2007;23:677-683 (Pubitemid 46767476)
202. Kanno T, Nonomura K, Katada K. Hyperbaric oxygen therapy to determine for surgical indication of hypertensive intracerebral hemorrhage and its hematoma evacuation by using CT-fluoroscopy. Jpn J Stroke 1996;18: 498-502
203. Tyler D, Mandybur G. Interventional MRI-guided stereotactic aspiration of acute/subacute intracerebral hematomas. Stereotact Funct Neurosurg 1999;72:129-135 (Pubitemid 30237257)
204. Iwamoto N, Kusaka M, Tsurutani T, et al. Ultrasound imaging for stereotactic evacuation of hypertensionassociated intracerebral hematomas with aqua-stream and aspiration. Stereotact Funct Neurosurg 1993;60:194-204 (Pubitemid 23185450)
205. Auer LM. Ultrasound stereotaxic endoscopy in neurosurgery. Acta Neurochir Suppl (Wien) 1992;54:34-41
206. Sugiyama N, Okura A, Katano H, et al. Measurement of intracranial pressure during CT-stereotactic hematoma evacuation. Prog Res Brain Edema ICP 2001;3:57-63 (in Japanese)
207. Carvi y Nievas MN, Haas E, et al. Combined minimal invasive techniques in deep supratentorial intracerebral haematomas. Minim Invasive Neurosurg 2004;47:294-298 (Pubitemid 39612500)
208. Barrett RJ, Hussain R, Coplin WM,et al. Frameless stereotactic aspiration and thrombolysis of spontaneous intracerebral hemorrhage. Neurocrit Care 2005;3:237-245 (Pubitemid 43004818)
209. Hillman J. Population-based analysis of arteriovenous malformation treatment. J Neurosurg 2001;95:633-637 (Pubitemid 33031425)
210. Al-Shahi R, Bhattacharya JJ, Currie DG, et al. Prospective, population-based detection of intracranial vascular malformations in adults: The Scottish Intracranial Vascular Malformation Study (SIVMS). Stroke 2003;34:1163-1169 (Pubitemid 36547507)
211. Crawford PM, West CR, Chadwick DW, et al. Arteriovenous malformations of the brain: Natural history in unoperated patients. J Neurol Neurosurg Psychiatry 1986;49:1-10 (Pubitemid 16155702)
212. Brown RD Jr, Wiebers DO, Forbes G, et al. The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg 1988;68:352-357 (Pubitemid 18067633)
213. Kim H, Sidney S, McCulloch CE, et al. Racial/ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke 2007;38:2430-2437 (Pubitemid 47329618)
214. Mast H, Young WL, Koennecke HC, et al. Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet 1997;350:1065-1068 (Pubitemid 27437857)
215. Yamada S, Takagi Y, Nozaki K, et al. Risk factors for subsequent hemorrhage in patients with cerebral arteriovenous malformations. J Neurosurg 2007;107:965-972 (Pubitemid 350255210)
216. Han PP, Ponce FA, Spetzler RF. Intention-to-treat analysis of Spetzler-Martin grades IV and V arteriovenous malformations: Natural history and treatment paradigm. J Neurosurg 2003;98:3-7 (Pubitemid 36050440)
217. Jayaraman MV, Marcellus ML, Do HM, et al. Hemorrhage rate in patients with Spetzler-Martin grades IV and V arteriovenous malformations: Is treatment justified? Stroke 2007;38:325-329 (Pubitemid 46184303)
218. Halim AX, Johnston SC, Singh V, et al. Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke 2004;35:1697-1702 (Pubitemid 38823650)
219. Turjman F, Massoud TF, Vinuela F, et al. Correlation of the angioarchitectural features of cerebral arteriovenous malformations with clinical presentation of hemorrhage. Neurosurgery 1995;37:856-860
220. Stefani MA, Porter PJ, terBrugge KG, et al. Large and deep brain arteriovenous malformations are associated with risk of future hemorrhage. Stroke 2002;33:1220-1224 (Pubitemid 34517039)
221. Stapf C, Mohr JP, Sciacca RR, et al. Incident hemorrhage risk of brain arteriovenous malformations located in the arterial border zones. Stroke 2000;31:2365-2368
222. Fullerton HJ, Achrol AS, Johnston SC, et al. Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke 2005;36:2099-2104 (Pubitemid 41429227)
223. Mansmann U, Meisel J, Brock M, et al. Factors associated with intracranial hemorrhage in cases of cerebral arteriovenous malformation. Neurosurgery 2000;46: 272-281 (Pubitemid 30094464)
224. Pollock BE, Flickinger JC, Lunsford LD, et al. Hemorrhage risk after stereotactic radiosurgery of cerebral arteriovenous malformations. Neurosurgery 1996;38: 652-661 (Pubitemid 26087870)
225. Meisel HJ, Mansmann U, Alvarez H, et al. Cerebral arteriovenous malformations and associated aneurysms: Analysis of 305 cases from a series of 662 patients. Neurosurgery 2000;46:793-802 (Pubitemid 30198783)
226. Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg 1986;65:476-483 (Pubitemid 16000693)
227. Hamilton MG, Spetzler RF. The prospective application of a grading system for arteriovenous malformations. Neurosurgery 1994;34:2-7 (Pubitemid 24015059)
228. Hartmann A, Stapf C, Hofmeister C, et al. Determinants of neurological outcome after surgery for brain arteriovenous malformation. Stroke 2000;31:2361-2364
229. Nozaki K, Hashimoto N, Miyamoto S, et al. Resectability of Spetzler-Martin grade IV and V cerebral arteriovenous malformations. J Clin Neurosci 2000;7(Suppl 1): 78-81
230. O'Laoire SA. Microsurgical treatment of arteriovenous malformations in critical areas of the brain. Br J Neurosurg 1995;9:347-360
231. Jafar JJ, Rezai AR. Acute surgical management of intracranial arteriovenous malformations. Neurosurgery 1994;34:8-13 (Pubitemid 24015060)
232. Lawton MT, Du R, Tran MN, et al. Effect of presenting hemorrhage on outcome after microsurgical resection of brain arteriovenous malformations. Neurosurgery 2005;56:485-493
233. Shimamoto Y, Asada H, Onozuka S, et al. Natural history for residual intracranial AVM compared with conservatively treated AVM. Neuro Surg 1992;20:931-936 (in Japanese)
234. Miyamoto S, Hashimoto N, Nagata I, et al. Posttreatment sequelae of palliatively treated cerebral arteriovenous malformations. Neurosurgery 2000;46:589-595 (Pubitemid 30146146)
235. Nozaki K, Hashimoto N, Kikuta K, et al. Surgical applications to arteriovenous malformations involving the brainstem. Neurosurgery 2006;58(4 Suppl 2):ONS270- ONS279
236. Deruty R, Pelissou-Guyotat I, Morel C, et al. Reflections on the management of cerebral arteriovenous malformations. Surg Neurol 1998;50:245-256 (Pubitemid 28415583)
237. Spetzler RF, Martin NA, Carter LP, et al. Surgical management of large AVMs by staged embolization and operative excision. J Neurosurg 1987;67:17-28 (Pubitemid 17085008)
238. DeMeritt JS, Pile-Spellman J, Mast H, et al. Outcome analysis of preoperative embolization with N-butyl cyanoacrylate in cerebral arteriovenous malformations. AJNR Am J Neuroradiol 1995;16:1801-1807
239. Raupp EF, Fernandes J. Does treatment with N-butyl cyanoacrylate embolization protect against hemorrhage in cerebral arteriovenous malformations? Arq Neuropsiquiatr 2005;63:34-39 (Pubitemid 40543414)
240. Meisel HJ, Mansmann U, Alvarez H, et al. Effect of partial targeted N-butyl-cyano-acrylate embolization in brain AVM. Acta Neurochir (Wien) 2002;144:879-888
241. Hartmann A, Pile-Spellman J, Stapf C, et al. Risk of endovascular treatment of brain arteriovenous malformations. Stroke 2002;33:1816-1820 (Pubitemid 34761067)
242. Valavanis A, Yasargil MG. The endovascular treatment of brain arteriovenous malformations. Adv Tech Stand Neurosurg 1998;24:131-214
243. Wikholm G, Lundqvist C, Svendsen P. The Goteborg cohort of embolized cerebral arteriovenous malformations: A 6-year follow-up. Neurosurgery 2001;49:799-806 (Pubitemid 32927950)
244. Choi JH, Mohr JP. Brain arteriovenous malformations in adults. Lancet Neurol 2005;4:299-308 (Pubitemid 40545041)
245. Henkes H, Nahser HC, Berg-Dammer E, et al. Endovascular therapy of brain AVMs prior to radiosurgery. Neurol Res 1998;20:479-492 (Pubitemid 28367259)
246. Castel JP, Kantor G. Postoperative morbidity and mortality after microsurgical exclusion of cerebral arteriovenous malformations: Current data and analysis of recent literature. Neurochirurgie 2001;47:369-383 (Pubitemid 32457805)
247. Taylor CL, Dutton K, Rappard G, et al. Complications of preoperative embolization of cerebral arteriovenous malformations. J Neurosurg 2004;100:810-812 (Pubitemid 38533963)
248. Steiner L, Lindquist C, Adler JR, et al. Clinical outcome of radiosurgery for cerebral arteriovenous malformations. J Neurosurg 1992;77:1-8
249. Lunsford LD, Kondziolka D, Flickinger JC, et al. Stereotactic radiosurgery for arteriovenous malformations of the brain. J Neurosurg 1991;75:512-524
250. Friedman WA, Bova FJ. Linear accelerator radiosurgery for arteriovenous malformations. J Neurosurg 1992;77: 832-841
251. Karlsson B, Lax I, Soderman M. Risk for hemorrhage during the 2-year latency period following gamma knife radiosurgery for arteriovenous malformations. Int J Radiat Oncol Biol Phys 2001;49:1045-1051 (Pubitemid 32184611)
252. Nakayama S, Fujino H, Nagano H, et al. Hemorrhage after gamma knife radiosurgery for cerebral arteriovenous malformations. Stereotact Radiother 2002;6:25-31 (in Japanese)
253. Friedman WA, Bova FJ, Bollampally S, et al. Analysis of factors predictive of success or complications in arteriovenous malformation radiosurgery. Neurosurgery 2003;52:296-308 (Pubitemid 36159416)
254. Karlsson B, Lax I, Soderman M. Factors influencing the risk for complications following gamma knife radiosurgery of cerebral arteriovenous malformations. Radiother Oncol 1997;43:275-280 (Pubitemid 27248472)
255. Yamamoto M, Jimbo M, Hara M, et al. Gamma knife radiosurgery for arteriovenous malformations: Long-term follow-up results focusing on complications occurring more than 5 years after irradiation. Neurosurgery 1996;38:906-914 (Pubitemid 26125551)
256. Maruyama K, Kawahara N, Shin M, et al. The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med 2005;352:146-153 (Pubitemid 40096611)
257. Yeh HS, Kashiwagi S, Tew JM Jr, et al. Surgical management of epilepsy associated with cerebral arteriovenous malformations. J Neurosurg 1990;72:216-223 (Pubitemid 20087710)
258. Yeh HS, Tew JM Jr, Gartner M. Seizure control after surgery on cerebral arteriovenous malformations. J Neurosurg 1993;78:12-18 (Pubitemid 23005347)
259. Schauble B, Cascino GD, Pollock BE, et al. Seizure outcomes after stereotactic radiosurgery for cerebral arteriovenous malformations. Neurology 2004;63:683-687 (Pubitemid 39100826)
260. Hoh BL, Chapman PH, Loeffler JS, et al. Results of multimodality treatment for 141 patients with brain arteriovenous malformations and seizures: Factors associated with seizure incidence and seizure outcome. Neurosurgery 2002;51:303-309
261. Bristol RE, Albuquerque FC, Spetzler RF, et al. Surgical management of arteriovenous malformations in children. J Neurosurg 2006;105(2 Suppl):88-93 (Pubitemid 44954778)
262. Nicolato A, Foroni R, Seghedoni A, et al. Leksell gamma knife radiosurgery for cerebral arteriovenous malformations in pediatric patients. Childs Nerv Syst 2005;21: 301-308
263. Kiris T, Sencer A, Sahinbas M, et al. Surgical results in pediatric Spetzler-Martin grades I-III intracranial arteriovenous malformations. Childs Nerv Syst 2005;21:69-76
264. Loh Y, Duckwiler GR for Onyx Trial Investigators. A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. J Neurosurg 2010;113:733-741
265. Kuwayama N, Kubo M, Hori E, et al. Epidemiological survey on intracranial and spinal dural arteriovenous fistulae in Japan. In: Grant-in-Aid for Scientific Research Study Report in FY2003-2004 (in Japanese)
266. Brown RD Jr, Wiebers DO, Torner JC, et al. Incidence and prevalence of intracranial vascular malformations in Olmsted County, Minnesota, 1965 to 1992. Neurology 1996;46:949-952 (Pubitemid 26134632)
267. Al-Shahi R, Bhattacharya JJ, Currie DG, et al. Prospective, population-based detection of intracranial vascular malformations in adults: The Scottish Intracranial Vascular Malformation Study (SIVMS). Stroke 2003;34:1163-1169 (Pubitemid 36547507)
268. Brown RD Jr, Wiebers DO, Nichols DA. Intracranial dural arteriovenous fistulae: Angiographic predictors of intracranial hemorrhage and clinical outcome in nonsurgical patients. J Neurosurg 1994;81:531-538 (Pubitemid 24303278)
269. Borden JA, Wu JK, Shucart WA. A proposed classification for spinal and cranial dural arteriovenous fistulous malformations and implications for treatment. J Neurosurg 1995;82:166-179
270. Satomi J, van Dijk JM, Terbrugge KG, et al. Benign cranial dural arteriovenous fistulas: Outcome of conservative management based on the natural history of the lesion. J Neurosurg 2002;97:767-770 (Pubitemid 35222395)
271. Van Dijik JM, Terbrugge KG, Willinsky RA, et al. Clinical course of cranial dural arteriovenous fistulas with longterm persistent cortical venous reflux. Stroke 2002;33:1233-1236 (Pubitemid 34517040)
272. Kubo M, Kuwayama N, Endo S. Updated knowledge required for specialists. Cerebrovascular disorders: Treatment strategy for dural arteriovenous fistula. Pract Current 2003;13:41-49 (in Japanese)
273. Collice M, D'Aliberti G, Arena O, et al. Surgical treatment of intracranial dural arteriovenous fistulae: Role of venous drainage. Neurosurgery 2000;47:56-67 (Pubitemid 32047763)
274. Kawaguchi S, Sakaki T. Surgical treatment of intrarcranial dural arteriovenous fistulas. Brain Nerve 2008;60:897-906 (in Japanese)
275. Duffau H, Lopes M, Janosevic V, et al. Early rebleeding from intracranial dural arteriovenous fistulas: Report of 20 cases and review of the literature. J Neurosurg 1999;90:78-84 (Pubitemid 29024743)
276. Lewis AI, Tomsick TA, Tew JM Jr. Management of tentorial dural arteriovenous malformations: Transarterial embolization combined with stereotactic radiation or surgery. J Neurosurg 1994;81:851-859 (Pubitemid 24373465)
277. Miyachi S. Endovascular treatment for dural arteriovenous fistula. Brain Nerve 2008;60:907-914 (in Japanese)
278. Awad IA, Little JR, Akarawi WP, et al. Intracranial dural arteriovenous malformations: Factors predisposing to an aggressive neurological course. J Neurosurg 1990;72: 839-850 (Pubitemid 20191505)
279. Lucas CP, Zabramski JM, Spetzler RF, et al. Treatment for intracranial dural arteriovenous malformations: A metaanalysis from the English language literature. Neurosurgery 1997;40:1119-1132 (Pubitemid 27251663)
280. Kinouchi H, Mizoi K, Takahashi A, et al. Dural arteriovenous shunts at the craniocervical junction. J Neurosurg 1998;89:755-761 (Pubitemid 28485535)
281. Koebbe CJ, Singhal D, Sheehan J, et al. Radiosurgery for dural arteriovenous fistulas. Surg Neurol 2005;64: 392-399
282. Kida Y, Yoshimoto M, Hasegawa T. Gamma knife radiosurgery for dural arterio-venous fistulas. Jpn J Neurosurg 2008;17:376-383 (in Japanese) (Pubitemid 351754055)
283. Simard JM, Garcia-Bengochea F, Ballinger WE Jr, et al. Cavernous angioma: A review of 126 collected and 12 new clinical cases. Neurosurgery 1986;18:162-172 (Pubitemid 16161278)
284. Aiba T, Tanaka R, Koike T, et al. Natural history of intracranial cavernous malformations. J Neurosurg 1995;83:56-59
285. Robinson JR, Awad IA, Little JR. Natural history of the cavernous angioma. J Neurosurg 1991;75:709-714
286. Barker FG 2nd, Amin-Hanjani S, Butler WE, et al. Temporal clustering of hemorrhages from untreated cavernous malformations of the central nervous system. Neurosurgery 2001;49:15-24
287. Farmer JP, Cosgrove GR, Villemure JG, et al. Intracerebral cavernous angiomas. Neurology 1988;38:1699-1704 (Pubitemid 18265032)
288. Kondziolka D, Lunsford LD, Kestle JR. The natural history of cerebral cavernous malformations. J Neurosurg 1995;83:820-824
289. Scott RM, Barnes P, Kupsky W, et al. Cavernous angiomas of the central nervous system in children. J Neurosurg 1992;76:38-46
290. Di Rocco C, Iannelli A, Tamburrini G. Surgical management of paediatric cerebral cavernomas. J Neurosurg Sci 1997;41:343-347
291. de Oliveira JG, Rassi-Neto A, Ferraz FA, et al. Neurosurgical management of cerebellar cavernous malformations. Neurosurg Focus 2006;21:e11
292. Pollock BE, Garces YI, Stafford SL, et al. Stereotactic radiosurgery for cavernous malformations. J Neurosurg 2000;93:987-991 (Pubitemid 32800608)
293. Kondziolka D, Lunsford LD, Flickinger JC, et al. Reduction of hemorrhage risk after stereotactic radiosurgery for cavernous malformations. J Neurosurg 1995;83:825-831
294. Kim DG, Choe WJ, Paek SH, et al. Radiosurgery of intracranial cavernous malformations. Acta Neurochir (Wien) 2002;144:869-878
295. Ferroli P, Sinisi M, Franzini A, et al. Brainstem cavernomas: Long-term results of microsurgical resection in 52 patients. Neurosurgery 2005;56:1203-1214
296. Zimmerman RS, Spetzler RF, Lee KS, et al. Cavernous malformations of the brain stem. J Neurosurg 1991;75:32-39
297. Fritschi JA, Reulen HJ, Spetzler RF, et al. Cavernous malformations of the brain stem: A review of 139 cases. Acta Neurochir (Wien) 1994;130:35-46 (Pubitemid 24340288)
298. Porter RW, Detwiler PW, Spetzler RF, et al. Cavernous malformations of the brainstem: Experience with 100 patients. J Neurosurg 1999;90:50-58 (Pubitemid 29024739)
299. Samii M, Eghbal R, Carvalho GA, et al. Surgical management of brainstem cavernomas. J Neurosurg 2001;95:825-832 (Pubitemid 33043356)
300. Steinberg GK, Chang S, Gewirtz RJ, et al. Microsurgical resection of brainstem, thalamic, and basal ganglia angiographically occult vascular malformations. Neurosurgery 2000;46:260-271 (Pubitemid 30094463)
301. Karlsson B, Kihlstrom L, Lindquist C, et al. Radiosurgery for cavernous malformations. J Neurosurg 1998;88:293-297 (Pubitemid 28063603)
302. Hasegawa T, McInerney J, Kondziolka D, et al. Longterm results after stereotactic radiosurgery for patients with cavernous malformations. Neurosurgery 2002;50:1190-1198 (Pubitemid 36322758)
303. Amin-Hanjani S, Ogilvy CS, Candia GJ, et al. Stereotactic radiosurgery for cavernous malformations: Kjellberg's experience with proton beam therapy in 98 cases at the Harvard cyclotron. Neurosurgery 1998;42:1229-1238 (Pubitemid 28264855)
304. Zabramski JM, Wascher TM, Spetzler RF, et al. The natural history of familial cavernous malformations: Results of an ongoing study. J Neurosurg 1994;80:422-432 (Pubitemid 24073002)
305. Abdulrauf SI, Kaynar MY, Awad IA.Acomparison of the clinical profile of cavernous malformations with and without associated venous malformations. Neurosurgery 1999;44:41-47 (Pubitemid 29016165)
306. Naff NJ, Wemmer J, Hoenig-Rigamonti K, et al. A longitudinal study of patients with venous malformations: Documentation of a negligible hemorrhage risk and benign natural history. Neurology 1998;50:1709-1714 (Pubitemid 28283239)
307. McLaughlin MR, Kondziolka D, Flickinger JC, et al. The prospective natural history of cerebral venous malformations. Neurosurgery 1998;43:195-201 (Pubitemid 28354628)
308. Garner TB, Del CurlingOJr, Kelly DL Jr, et al. The natural history of intracranial venous angiomas. J Neurosurg 1991;75:715-722
309. Rigamonti D, Spetzler RF, Medina M, et al. Cerebral venous malformations. J Neurosurg 1990;73:560-564 (Pubitemid 20319475)
310. Wilms G, Bleus E, Demaerel P, et al. Simultaneous occurrence of developmental venous anomalies and cavernous angiomas. AJNR Am J Neuroradiol 1994;15:1247-1257 (Pubitemid 24257849)
311. Malik GM, Morgan JK, Boulos RS, et al. Venous angiomas: An underestimated cause of intracranial hemorrhage. Surg Neurol 1988;30:350-358 (Pubitemid 19004637)
312. Lupret V, Negovetic L, Smiljanic D, et al. Cerebral venous angiomas: Surgery as a mode of treatment for selected cases. Acta Neurochir (Wien) 1993;120:33-39 (Pubitemid 23057365)
313. Lindquist C, Guo WY, Karlsson B, et al. Radiosurgery for venous angiomas. J Neurosurg 1993;78:531-536 (Pubitemid 23099460)
314. Nutt SH, Patchell RA. Intracranial hemorrhage associated with primary and secondary tumors. Neurosurg Clin N Am 1992;3:591-599
315. Bills DC, Meyer FB, Laws ER Jr, et al. A retrospective analysis of pituitary apoplexy. Neurosurgery 1993;33:602-609 (Pubitemid 23292751)
316. Hankey GJ, Sudlow CL, Dunbabin DW. Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials. Stroke 2000;31:1779-1784 (Pubitemid 30437537)
317. Butler AC, Tait RC. Management of oral anticoagulantinduced intracranial haemorrhage. Blood Rev 1998;12: 35-44 (Pubitemid 28205974)
318. Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: A meta-analysis. Ann Intern Med 2003;139:893-900
319. Gorter JW; Stroke Prevention in Reversible Ischemia Trial (SPIRIT) and European Atrial Fibrillation Trial (EAFT) Study Groups. Major bleeding during anticoagulation after cerebral ischemia: Patterns and risk factors. Neurology 1999;53:1319-1327 (Pubitemid 29480094)
320. Johnsen SP, Pedersen L, Friis S, et al. Nonaspirin nonsteroidal anti-inflammatory drugs and risk of hospitalization for intracerebral hemorrhage: A population-based case-control study. Stroke 2003;34:387-391 (Pubitemid 36206335)
321. Berge E, Abdelnoor M, Nakstad PH, et al; HAEST (Heparin in Acute Embolic Stroke Trial) Study Group. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: A double- blind randomised study. Lancet 2000;355:1205-1210 (Pubitemid 30184528)
322. Turi ZG, Goldberg S, LittleJohn JK, et al; Wellcome Tissue Plasminogen Activator Study Group. Dose-related efficacy and bleeding complications of double-chain tissue plasminogen activator in acute myocardial infarction. Am J Cardiol 1993;71:1009-1014 (Pubitemid 23126805)
323. Gore JM, Granger CB, Simoons ML, et al. Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I (Global Use of Strategies to Open Occluded Coronary Arteries) Trial. Circulation 1995;92:2811-2818
324. Mikkola KM, Patel SR, Parker JA, et al. Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis. Am Heart J 1997;134:69-72 (Pubitemid 27329025)
325. Gurwitz JH, Gore JM, Goldberg RJ, et al. Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2. Ann Intern Med 1998;129:597-604 (Pubitemid 28480814)
326. Ueda T, Hatakeyama T, Kumon Y, et al. Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT. Stroke 1994;25:298-303 (Pubitemid 24047249)
327. Albers GW, Bates VE, Clark WM, et al. Intravenous tissue- type plasminogen activator for treatment of acute stroke: The Standard Treatment with Alteplase to Reverse Stroke (STARS) Study. JAMA 2000;283:1145-1150 (Pubitemid 30126602)
328. Kase CS, Furlan AJ, Wechsler LR, et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: The PROACT II trial. Neurology 2001;57:1603-1610 (Pubitemid 33055477)
329. Tanne D, Kasner SE, Demchuk AM, et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: The Multicenter rt-PA Stroke Survey. Circulation 2002;105:1679-1685 (Pubitemid 34298612)
330. Selim M, Fink JN, Kumar S, et al. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: Prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume. Stroke 2002;33:2047-2052 (Pubitemid 34840066)
331. Simoons ML, Maggioni AP, Knatterud G, et al. Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet 1993;342:1523-1528 (Pubitemid 23362173)
332. Berwaerts J, Webster J. Analysis of risk factors involved in oral anticoagulant-related intracranial haemorrhages. QJM 2000;93:513-521 (Pubitemid 30623787)
333. Rosand J, Hylek EM, O'Donnell HC, et al. Warfarin-associated hemorrhage and cerebral amyloid angiopathy:a genetic and pathologic study. Neurology 2000;55:947-951
334. Copland M, Walker ID, Tait RC. Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation. Arch Intern Med 2001;161:2125-2128
335. Yamaguchi T; Japanese Nonvalvular Atrial Fibrillation- Embolism Secondary Prevention Cooperative Study Group. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: A multicenter, prospective, randomized trial. Stroke 2000;31:817-821 (Pubitemid 30198421)
336. Phan TG, Koh M, Wijdicks EF. Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk. Arch Neurol 2000;57:1710-1713
337. Bertram M, Bonsanto M, Hacke W, et al. Managing the therapeutic dilemma: Patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation. J Neurol 2000;247:209-214 (Pubitemid 30189404)
338. Fredriksson K, Norrving B, Stromblad LG. Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke 1992;23:972-977
339. Makris M, Greaves M, Phillips WS, et al. Emergency oral anticoagulant reversal: The relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost 1997;77:477-480 (Pubitemid 27121012)
340. Roitberg B, Emechebe-Kennedy O, Amin-Hanjani S, et al. Human recombinant factor VII for emergency reversal of coagulopathy in neurosurgical patients: A retrospective comparative study. Neurosurgery 2005;57:832-836
341. Huttner HB, Schellinger PD, Hartmann M, et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: Comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke 2006;37:1465-1470 (Pubitemid 44305727)
342. Mahaffey KW, Granger CB, Sloan MA, et al. Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: Experience from the GUSTO-I trial. Global Utilization of Streptokinase and Tissue-Plasminogen Activator (tPA) for Occluded Coronary Arteries. Am Heart J 1999;138:493-499 (Pubitemid 29428772)
343. Sjoblom L, Hardemark HG, Lindgren A, Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: A Swedish multicenter study. Stroke 2001;32:2567-2574 (Pubitemid 33055307)
344. Roquer J, Rodriguez Campello A, Gomis M, et al. Previous antiplatelet therapy is an independent predictor of 30-day mortality after spontaneous supratentorial intracerebral hemorrhage. J Neurol 2005;252:412-416 (Pubitemid 40576903)
345. Toyoda K, Okada Y, Minematsu K, et al. Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage. Neurology 2005;65:1000-1004 (Pubitemid 41429621)
346. Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in highrisk patients (MATCH): Randomised, double-blind, placebo- controlled trial. Lancet 2004;364:331-337
347. Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706-1717
348. Hart RG, Tonarelli SB, Pearce LA. Avoiding central nervous system bleeding during antithrombotic therapy: Recent data and ideas. Stroke 2005;36:1588-1593 (Pubitemid 40967537)
349. Barron HV, Rundle AC, Gore JM, et al. Intracranial hemorrhage rates and effect of immediate beta-blocker use in patients with acute myocardial infarction treated with tissue plasminogen activator. Participants in the National Registry of Myocardial Infarction 2. Am J Cardiol 2000;85:294-298 (Pubitemid 30052899)
350. Kaufman HH, McAllister P, Taylor H, Schmidt S. Intracerebral hematoma related to thrombolysis for myocardial infarction. Neurosurgery 1993;33:898-900
351. Onoyama K, Kumagai H, Miishima T, et al. Incidence of stroke and its prognosis in patients on maintenance hemodialysis. Jpn Heart J 1986;27:685-691 (Pubitemid 17212541)
352. Iseki K, Kinjo K, Kimura Y, et al. Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int 1993;44:1086-1090 (Pubitemid 23316478)
353. Kawamura M, Fujimoto S, Hisanaga S, et al. Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis. Am J Kidney Dis 1998;31:991-996 (Pubitemid 28265196)
354. Iseki K, Fukiyama K; Okinawa Dialysis Study (OKIDS) Group. Clinical demographics and long-term prognosis after stroke in patients on chronic haemodialysis. Nephrol Dial Transplant 2000;15:1808-1813
355. Seliger SL, Gillen DL, Longstreth WT Jr, et al. Elevated risk of stroke among patients with end-stage renal disease. Kidney Int 2003;64:603-609 (Pubitemid 36871932)
356. Toyoda K, Fujii K, Fujimi S, et al. Stroke in patients on maintenance hemodialysis: A 22-year single-center study. Am J Kidney Dis 2005;45:1058-1066 (Pubitemid 40806519)
357. Onoyama K, Ibayashi S, Nanishi F, et al. Cerebral hemorrhage in patients on maintenance hemodialysis: CT analysis of 25 cases. Eur Neurol 1987;26:171-175 (Pubitemid 17048769)
358. Mizobuchi Y, Uno M, Kouno T, et al. Management and clinical outcome of cerebral hemorrhage in patients with chronic renal failure. Surg Cereb Stroke 2003;31:290-294
359. Watanabe A. Cerebral microbleeds and intracerebral hemorrhages in patients on maintenance hemodialysis. J Stroke Cerebrovasc Dis 2007;16:30-33 (Pubitemid 46073789)
360. Krane NK. Intracranial pressure measurement in a patient undergoing hemodialysis and peritoneal dialysis. Am J Kidney Dis 1989;13:336-339 (Pubitemid 19109087)
361. Murakami M, Hamasaki T, Kimura S, et al. Clinical features and management of intracranial hemorrhage in patients undergoing maintenance dialysis therapy. Neurol Med Chir (Tokyo) 2004;44:225-233
362. Kitamura N, Hirasawa H. Blood purification in critical care: Blood purification in patients with acute-phase neurosurgical diseases accompanied by renal failure. Jpn J Acute Med 1993;17:207-209 (in Japanese)
363. Tsurushima H, Kamezaki T, Yamabe-Nakamura H, et al. Management of putaminal hemorrhage in patients with chronic renal failure. Neuro Surg 1988;26:897-901 (in Japanese)
364. Akizawa T, Koshikawa S, Ota K, et al. Nafamostat mesilate: A regional anticoagulant for hemodialysis in patients at high risk for bleeding. Nephron 1993;64:376-381 (Pubitemid 23202844)
365. Yasumori R, Watanabe S, Akashi M, et al. Two cases of CT-guided stereotactic hematoma evacuation for intracerebral hemorrhage in patients on maintenance hemodialysis. J Jpn Soc Dialysis Ther 1994;27:123-128 (in Japanese)
366. GondoG, Yamanaka Y, Fujii S, et al. Treatment strategy for cerebral apoplectic patients with renal failure. Surg Cereb Stroke 2000;28:248-253 (in Japanese)